Global Ophthalmology Drugs Market Size, Status and Forecast 2019-2025

Choose Licence

 

Ophthalmology is a broad therapy area that consists of almost 100 disorders associated with the eyes and visual system, including such diseases as glaucoma, age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR) and dry eye syndrome (DES). Many of these disorders are progressive, and if left untreated can lead to severe visual impairment or even blindness. Of the five key indications within the therapy area - glaucoma, AMD, DME, DR and DES - glaucoma and AMD have the most active product pipelines. In 2018, the global Ophthalmology Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Ophthalmology Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ophthalmology Drugs development in United States, Europe and China. The key players covered in this study Novartis Regeneron Roche Bayer Allergan Shire Mallinckrodt Santen Pharmaceutical? Aerie Market segment by Type, the product can be split into Lucentis (Ranibizumab) Eylea (Aflibercept) Avastin (Bevacizumab) Restasis (Cyclosporine) Alphagan (Brimonidine Tartrate) Lumigan (Bimatoprost) Xalatan (Latanoprost) Conclusion Market segment by Application, split into Hospital Pharmacies Retail Pharmacies Drug Stores Online Sales Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Ophthalmology Drugs status, future forecast, growth opportunity, key market and key players. To present the Ophthalmology Drugs development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Ophthalmology Drugs are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 

Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Ophthalmology Drugs Market Size Growth Rate by Type (2014-2025) 1.4.2 Lucentis (Ranibizumab) 1.4.3 Eylea (Aflibercept) 1.4.4 Avastin (Bevacizumab) 1.4.5 Restasis (Cyclosporine) 1.4.6 Alphagan (Brimonidine Tartrate) 1.4.7 Lumigan (Bimatoprost) 1.4.8 Xalatan (Latanoprost) 1.4.9 Conclusion 1.5 Market by Application 1.5.1 Global Ophthalmology Drugs Market Share by Application (2014-2025) 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Drug Stores 1.5.5 Online Sales 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Ophthalmology Drugs Market Size 2.2 Ophthalmology Drugs Growth Trends by Regions 2.2.1 Ophthalmology Drugs Market Size by Regions (2014-2025) 2.2.2 Ophthalmology Drugs Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Ophthalmology Drugs Market Size by Manufacturers 3.1.1 Global Ophthalmology Drugs Revenue by Manufacturers (2014-2018) 3.1.2 Global Ophthalmology Drugs Revenue Market Share by Manufacturers (2014-2018) 3.1.3 Global Ophthalmology Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Ophthalmology Drugs Key Players Head office and Area Served 3.3 Key Players Ophthalmology Drugs Product/Solution/Service 3.4 Date of Enter into Ophthalmology Drugs Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Ophthalmology Drugs Market Size by Type (2014-2019) 4.2 Global Ophthalmology Drugs Market Size by Application (2014-2019) 5 United States 5.1 United States Ophthalmology Drugs Market Size (2014-2019) 5.2 Ophthalmology Drugs Key Players in United States 5.3 United States Ophthalmology Drugs Market Size by Type 5.4 United States Ophthalmology Drugs Market Size by Application 6 Europe 6.1 Europe Ophthalmology Drugs Market Size (2014-2019) 6.2 Ophthalmology Drugs Key Players in Europe 6.3 Europe Ophthalmology Drugs Market Size by Type 6.4 Europe Ophthalmology Drugs Market Size by Application 7 China 7.1 China Ophthalmology Drugs Market Size (2014-2019) 7.2 Ophthalmology Drugs Key Players in China 7.3 China Ophthalmology Drugs Market Size by Type 7.4 China Ophthalmology Drugs Market Size by Application 8 Japan 8.1 Japan Ophthalmology Drugs Market Size (2014-2019) 8.2 Ophthalmology Drugs Key Players in Japan 8.3 Japan Ophthalmology Drugs Market Size by Type 8.4 Japan Ophthalmology Drugs Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Ophthalmology Drugs Market Size (2014-2019) 9.2 Ophthalmology Drugs Key Players in Southeast Asia 9.3 Southeast Asia Ophthalmology Drugs Market Size by Type 9.4 Southeast Asia Ophthalmology Drugs Market Size by Application 10 India 10.1 India Ophthalmology Drugs Market Size (2014-2019) 10.2 Ophthalmology Drugs Key Players in India 10.3 India Ophthalmology Drugs Market Size by Type 10.4 India Ophthalmology Drugs Market Size by Application 11 Central & South America 11.1 Central & South America Ophthalmology Drugs Market Size (2014-2019) 11.2 Ophthalmology Drugs Key Players in Central & South America 11.3 Central & South America Ophthalmology Drugs Market Size by Type 11.4 Central & South America Ophthalmology Drugs Market Size by Application 12 International Players Profiles 12.1 Novartis 12.1.1 Novartis Company Details 12.1.2 Company Description and Business Overview 12.1.3 Ophthalmology Drugs Introduction 12.1.4 Novartis Revenue in Ophthalmology Drugs Business (2014-2019) 12.1.5 Novartis Recent Development 12.2 Regeneron 12.2.1 Regeneron Company Details 12.2.2 Company Description and Business Overview 12.2.3 Ophthalmology Drugs Introduction 12.2.4 Regeneron Revenue in Ophthalmology Drugs Business (2014-2019) 12.2.5 Regeneron Recent Development 12.3 Roche 12.3.1 Roche Company Details 12.3.2 Company Description and Business Overview 12.3.3 Ophthalmology Drugs Introduction 12.3.4 Roche Revenue in Ophthalmology Drugs Business (2014-2019) 12.3.5 Roche Recent Development 12.4 Bayer 12.4.1 Bayer Company Details 12.4.2 Company Description and Business Overview 12.4.3 Ophthalmology Drugs Introduction 12.4.4 Bayer Revenue in Ophthalmology Drugs Business (2014-2019) 12.4.5 Bayer Recent Development 12.5 Allergan 12.5.1 Allergan Company Details 12.5.2 Company Description and Business Overview 12.5.3 Ophthalmology Drugs Introduction 12.5.4 Allergan Revenue in Ophthalmology Drugs Business (2014-2019) 12.5.5 Allergan Recent Development 12.6 Shire 12.6.1 Shire Company Details 12.6.2 Company Description and Business Overview 12.6.3 Ophthalmology Drugs Introduction 12.6.4 Shire Revenue in Ophthalmology Drugs Business (2014-2019) 12.6.5 Shire Recent Development 12.7 Mallinckrodt 12.7.1 Mallinckrodt Company Details 12.7.2 Company Description and Business Overview 12.7.3 Ophthalmology Drugs Introduction 12.7.4 Mallinckrodt Revenue in Ophthalmology Drugs Business (2014-2019) 12.7.5 Mallinckrodt Recent Development 12.8 Santen Pharmaceutical? 12.8.1 Santen Pharmaceutical? Company Details 12.8.2 Company Description and Business Overview 12.8.3 Ophthalmology Drugs Introduction 12.8.4 Santen Pharmaceutical? Revenue in Ophthalmology Drugs Business (2014-2019) 12.8.5 Santen Pharmaceutical? Recent Development 12.9 Aerie 12.9.1 Aerie Company Details 12.9.2 Company Description and Business Overview 12.9.3 Ophthalmology Drugs Introduction 12.9.4 Aerie Revenue in Ophthalmology Drugs Business (2014-2019) 12.9.5 Aerie Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Ophthalmology Drugs Key Market Segments Table Key Players Ophthalmology Drugs Covered Table Global Ophthalmology Drugs Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Ophthalmology Drugs Market Size Market Share by Type 2014-2025 Figure Lucentis (Ranibizumab) Figures Table Key Players of Lucentis (Ranibizumab) Figure Eylea (Aflibercept) Figures Table Key Players of Eylea (Aflibercept) Figure Avastin (Bevacizumab) Figures Table Key Players of Avastin (Bevacizumab) Figure Restasis (Cyclosporine) Figures Table Key Players of Restasis (Cyclosporine) Figure Alphagan (Brimonidine Tartrate) Figures Table Key Players of Alphagan (Brimonidine Tartrate) Figure Lumigan (Bimatoprost) Figures Table Key Players of Lumigan (Bimatoprost) Figure Xalatan (Latanoprost) Figures Table Key Players of Xalatan (Latanoprost) Figure Conclusion Figures Table Key Players of Conclusion Table Global Ophthalmology Drugs Market Size Growth by Application 2014-2025 (Million US$) Figure Hospital Pharmacies Case Studies Figure Retail Pharmacies Case Studies Figure Drug Stores Case Studies Figure Online Sales Case Studies Figure Ophthalmology Drugs Report Years Considered Table Global Ophthalmology Drugs Market Size 2014-2025 (Million US$) Figure Global Ophthalmology Drugs Market Size and Growth Rate 2014-2025 (Million US$) Table Global Ophthalmology Drugs Market Size by Regions 2014-2025 (Million US$) Table Global Ophthalmology Drugs Market Size by Regions 2014-2019 (Million US$) Table Global Ophthalmology Drugs Market Share by Regions 2014-2019 Figure Global Ophthalmology Drugs Market Share by Regions 2014-2019 Figure Global Ophthalmology Drugs Market Share by Regions 2019 Table Market Top Trends Table Global Ophthalmology Drugs Revenue by Manufacturers (2014-2019) (Million US$) Table Global Ophthalmology Drugs Market Share by Manufacturers (2014-2019) Figure Global Ophthalmology Drugs Market Share by Manufacturers in 2018 Table Global Ophthalmology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Ophthalmology Drugs Product/Solution/Service Table Date of Enter into Ophthalmology Drugs Market Table Mergers & Acquisitions, Expansion Plans Table Global Ophthalmology Drugs Market Size by Type (2014-2019) (Million US$) Table Global Ophthalmology Drugs Market Size Share by Type (2014-2019) Figure Global Ophthalmology Drugs Market Size Market Share by Type (2014-2019) Table Global Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$) Table Global Ophthalmology Drugs Market Size Share by Application (2014-2019) Figure Global Ophthalmology Drugs Market Size Market Share by Application (2014-2019) Figure Global Ophthalmology Drugs Revenue Market Share by Application in 2018 Figure United States Ophthalmology Drugs Market Size 2014-2019 (Million US$) Table United States Key Players Ophthalmology Drugs Revenue (2018-2019) (Million US$) Table United States Key Players Ophthalmology Drugs Market Share (2018-2019) Table United States Ophthalmology Drugs Market Size by Type (2014-2019) (Million US$) Table United States Ophthalmology Drugs Market Share by Type (2014-2019) Table United States Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$) Table United States Ophthalmology Drugs Market Share by Application (2014-2019) Figure Europe Ophthalmology Drugs Market Size 2014-2019 (Million US$) Table Europe Key Players Ophthalmology Drugs Revenue (2018-2019) (Million US$) Table Europe Key Players Ophthalmology Drugs Market Share (2018-2019) Table Europe Ophthalmology Drugs Market Size by Type (2014-2019) (Million US$) Table Europe Ophthalmology Drugs Market Share by Type (2014-2019) Table Europe Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$) Table Europe Ophthalmology Drugs Market Share by Application (2014-2019) Figure China Ophthalmology Drugs Market Size 2014-2019 (Million US$) Table China Key Players Ophthalmology Drugs Revenue (2018-2019) (Million US$) Table China Key Players Ophthalmology Drugs Market Share (2018-2019) Table China Ophthalmology Drugs Market Size by Type (2014-20189) (Million US$) Table China Ophthalmology Drugs Market Share by Type (2014-2019) Table China Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$) Table China Ophthalmology Drugs Market Share by Application (2014-2019) Figure Japan Ophthalmology Drugs Market Size 2014-2019 (Million US$) Table Japan Key Players Ophthalmology Drugs Revenue (2018-2019) (Million US$) Table Japan Key Players Ophthalmology Drugs Market Share (2018-2019) Table Japan Ophthalmology Drugs Market Size by Type (2014-2019) (Million US$) Table Japan Ophthalmology Drugs Market Share by Type (2014-2019) Table Japan Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$) Table Japan Ophthalmology Drugs Market Share by Application (2014-2019) Figure Southeast Asia Ophthalmology Drugs Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Ophthalmology Drugs Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Ophthalmology Drugs Market Share (2018-2019) Table Southeast Asia Ophthalmology Drugs Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Ophthalmology Drugs Market Share by Type (2014-2019) Table Southeast Asia Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Ophthalmology Drugs Market Share by Application (2014-2019) Figure India Ophthalmology Drugs Market Size 2014-2019 (Million US$) Table India Key Players Ophthalmology Drugs Revenue (2018-2019) (Million US$) Table India Key Players Ophthalmology Drugs Market Share (2018-2019) Table India Ophthalmology Drugs Market Size by Type (2014-2019) (Million US$) Table India Ophthalmology Drugs Market Share by Type (2014-2019) Table India Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$) Table India Ophthalmology Drugs Market Share by Application (2014-2019) Figure Central & South America Ophthalmology Drugs Market Size 2014-2019 (Million US$) Table Central & South America Key Players Ophthalmology Drugs Revenue (2018-2019) (Million US$) Table Central & South America Key Players Ophthalmology Drugs Market Share (2018-2019) Table Central & South America Ophthalmology Drugs Market Size by Type (2014-2019) (Million US$) Table Central & South America Ophthalmology Drugs Market Share by Type (2014-2019) Table Central & South America Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$) Table Central & South America Ophthalmology Drugs Market Share by Application (2014-2019) Table Novartis Company Details Table Novartis Revenue in Ophthalmology Drugs Business (2014-2019) (Million US$) Figure Novartis Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019) Table Novartis Recent Development Table Regeneron Company Details Table Regeneron Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$) Figure Regeneron Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019) Table Regeneron Recent Development Table Roche Company Details Table Roche Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$) Figure Roche Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019) Table Roche Recent Development Table Bayer Company Details Table Bayer Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$) Figure Bayer Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019) Table Bayer Recent Development Table Allergan Company Details Table Allergan Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$) Figure Allergan Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019) Table Allergan Recent Development Table Shire Company Details Table Shire Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$) Figure Shire Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019) Table Shire Recent Development Table Mallinckrodt Company Details Table Mallinckrodt Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$) Figure Mallinckrodt Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019) Table Mallinckrodt Recent Development Table Santen Pharmaceutical? Company Details Table Santen Pharmaceutical? Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$) Figure Santen Pharmaceutical? Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019) Table Santen Pharmaceutical? Recent Development Table Aerie Company Details Table Aerie Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$) Figure Aerie Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019) Table Aerie Recent Development Table Global Ophthalmology Drugs Market Size by Regions (Million US$) 2019-2025 Figure Global Ophthalmology Drugs Market Size Share by Regions (2019-2025) Figure Global Ophthalmology Drugs Market Size Share by Regions in 2025 Figure United States Ophthalmology Drugs Market Size Forecast (2019-2025)(Million USD) Figure Europe Ophthalmology Drugs Market Size Forecast (2019-2025)(Million USD) Figure China Ophthalmology Drugs Market Size Forecast (2019-2025)(Million USD) Figure Japan Ophthalmology Drugs Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Ophthalmology Drugs Market Size Forecast (2019-2025)(Million USD) Figure India Ophthalmology Drugs Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Ophthalmology Drugs Market Size Forecast (2019-2025)(Million USD) Table Global Ophthalmology Drugs Market Size by Product (2019-2025) (Million US$) Figure Global Ophthalmology Drugs Market Size by Product (2019-2025) Figure Global Ophthalmology Drugs Market Size by Product in 2025 Table Global Ophthalmology Drugs Market Size by Application (2019-2025) (Million US$) Figure Global Ophthalmology Drugs Market Size by Application (2019-2025) Figure Global Ophthalmology Drugs Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global Linear Displacement Sensor Market Research Report 2019

The global Linear Displacement Sensor market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Linear Displacement Sensor volume and value at global...

Global Crimping Heads Market Research Report 2019

The global Crimping Heads market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Crimping Heads volume and value at global level, regional level a...

Global Positive Displacement Counters Market Research Report 2019

The global Positive Displacement Counters market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Positive Displacement Counters volume and value a...

Global Torsionally Rigid Coupling Market Research Report 2019

The global Torsionally Rigid Coupling market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Torsionally Rigid Coupling volume and value at global...

Global Elevator Cable Tensiometers Market Research Report 2019

The global Elevator Cable Tensiometers market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Elevator Cable Tensiometers volume and value at glob...

New Pharmaceuticals and Healthcare Reports